Skip to main content
Clinical Trials/NCT04450303
NCT04450303
Completed
N/A

Social Anxiety Telehealth Therapy Study

Stanford University1 site in 1 country26 target enrollmentOctober 30, 2020
ConditionsSocial Anxiety

Overview

Phase
N/A
Intervention
Not specified
Conditions
Social Anxiety
Sponsor
Stanford University
Enrollment
26
Locations
1
Primary Endpoint
Satisfaction with Therapy and Therapists Scale (STTS)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.

Registry
clinicaltrials.gov
Start Date
October 30, 2020
End Date
June 2, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tali Manber Ball, PhD

Instructor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Liebowitz Social Anxiety Scale (LSAS) total score \> 50
  • Fluent spoken and written English
  • Access to the internet via a smartphone or computer with a camera
  • Ability to provide informed consent.

Exclusion Criteria

  • History of mania or psychosis
  • Moderate or severe substance use disorder within the past year
  • Current psychiatric diagnosis of greater impairment than that arising from social anxiety
  • High risk for suicide (\>8 on the Mini International Neuropsychiatric Interview suicidality section)
  • Prior exposure therapy (more than 2 sessions)
  • Current psychotropic medication use
  • Current psychotherapy other than couples counseling.

Outcomes

Primary Outcomes

Satisfaction with Therapy and Therapists Scale (STTS)

Time Frame: 12 weeks

Therapy satisfaction subscale, higher scores are better (indicating greater satisfaction). Minimum score is 6, maximum score is 30.

Liebowitz Social Anxiety Scale (LSAS)

Time Frame: 12 weeks

Social anxiety severity, lower scores are better (indicating less anxiety). Minimum score is 0, maximum score is 144.

UCLA Loneliness Scale version 3

Time Frame: 12 weeks

Loneliness, lower scores are better (indicating less loneliness). Minimum score is 20, maximum score is 80.

Secondary Outcomes

  • Liebowitz Social Anxiety Scale (LSAS)(24 weeks)
  • UCLA Loneliness Scale version 3(24 weeks)

Study Sites (1)

Loading locations...

Similar Trials